Pure Global

TipTraQ Home Sleep Test Validation Study - Trial NCT06351878

Access comprehensive clinical trial information for NCT06351878 through Pure Global AI's free database. This phase not specified trial is sponsored by PranaQ Pte. Ltd. and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 125 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06351878
Recruiting
Trial Details
ClinicalTrials.gov โ€ข NCT06351878
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
TipTraQ Home Sleep Test Validation Study
Validation of a Medical-grade Wearable Device With Interpretable Artificial Intelligence System for the Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS) Screening

Study Focus

Obstructive Sleep Apnea

Observational

Sponsor & Location

PranaQ Pte. Ltd.

Durham, United States of America

Timeline & Enrollment

N/A

Feb 28, 2024

Aug 23, 2024

125 participants

Primary Outcome

Apnea Hypopnea Index(AHI),Oxygen Desaturation Index(ODI),Total Sleep Time(TST)

Summary

A validation study has been designed to assess the performance of a home sleep test device,
 TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ
 device on their fingertip during a traditional sleep test, known as polysomnography (PSG),
 conducted in a sleep center. The performance of the device will then be evaluated by
 comparing the results from the TipTraQ system with those from the traditional sleep test.

ICD-10 Classifications

Sleep apnoea
Sleep disorders
Sleep disorder, unspecified
Primary sleep apnoea of newborn
Nonorganic sleep disorders

Data Source

ClinicalTrials.gov

NCT06351878

Non-Device Trial